Clinical efficacy and safety of a beta3-adrenoceptor agonist and an antimuscarinic agent in female patients with overactive overactive bladder: a randomized crossover study
Not Applicable
- Conditions
- Overactive bladder
- Registration Number
- JPRN-UMIN000010060
- Lead Sponsor
- ara Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Postvoid residual urine 50 mL and more, 2. Active urinary tract infection, 3. Histories of malignant tumors in the lower urinary tract, 4. Histories of surgery for the lower urinary tract in the last 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method